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ABSTRACT
1. Introduction: Scrub typhus is a mite-borne infectious disease caused 
by Orientia tsutsugamushi. Huaiyangshan banyangvirus (formerly Severe 
fever with thrombocytopenia syndrome virus (SFTSV)) is a tick-borne 
virus that can cause hemorrhagic fever. Severe fever with 
thrombocytopenia syndrome (SFTS) is emerging in Eastern Asia, including 
China, South Korea, and Japan, which are endemic region of scrub typhus. 
As the two infections overlap epidemiologically and clinically, knowledge on 
the local prevalence of the vector-borne infections is critical in 
target-oriented investigation and treatment.
2. Methods: To investigate the genotypic diversity of O. tsutsugamushi and 
potential coinfection with SFTSV in South Korea and Myanmar, 2,328 sera 
collected from patients with acute febrile illness in South Korea from 2000 
to 2003 and 152 sera obtained from suspected patients with scrub  typhus 
in Myanmar during 2018 were examined. I performed serological and 
molecular diagnosis of scrub typhus and SFTS. Phylogenetic analysis of 
both pathogens were also performed by sequencing of the amplified genes 
from O. tsutsugamushi and SFTSV.
3. Results: Among 2,328 samples from Korean patients, serological 
analysis detecting specific IgG against SFTSV NP antigen identified 37 
positive samples (1.6%). Molecular detection of SFTSV NP gene and 
O. tsutsugamushi tsa56 gene by PCR using the 37 specimens revealed 9 
positive for SFTSV and 14 positive for O. tsutsugamushi, respectively. 
Sequencing of 14 Orientia-specific PCR products showed the presence of 
3 genotypes, including Boryong (1/37, 2.7%), Karp (8/37, 21.6%) and 
Gilliam (4/37, 10.8%) genotypes. In addition, 4 specimens were positive 
for both SFTSV NP gene and O. tsutsugamushi tsa56 gene, indicating 
coinfections. Among 152 Myanmar samples, 9 samples (5.9%) were 
positive for O. tsutsugamushi tsa56 gene and sequencing of the PCR 
products revealed the presence of 5 genotypes, Karp A (4/9, 44,4%), Karp 
B (1/9, 11.1%), Kato B (2/9, 22.2%), Gilliam (1/9, 11.1%) and JG_C (1/9, 
11.1%). 5 samples were positive for SFTSV NP gene-specific PCR 
(5/152, 3.28%). These 5 SFTSV NP gene positive samples were all 
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negative for O. tsutsugamushi tsa56 gene, but 3 of them carried high titers 
(≥1:2,560) of IgG or IgM or both antibodies specific to O. tsutsugamushi, 
as measured by indirect immunofluorescence assay.
4. Conclusion: In this study, serological and molecular surveillance of 
sera collected from suspected scrub typhus patients in South Korea and 
Myanmar revealed serological prevalence and genotypic heterogeneity of  
O. tsutsutsugamushi. Moreover, potential coinfection of O. tsutsugamushi 
and SFTSV was identified by serological and molecular surveillance. These 
results suggest that SFTSV infections might have been spread more widely 
in Eastern Asia. Therefore, continuous surveillance of SFTS patients needs 
to be conducted in the local area. In addition, more reliable differential 
diagnosis techniques and prevention and control measures are required for 
better clinical practices and outcomes in the endemic regions of multiple 
tick-borne and mite-borne pathogens. 
----------------------------------------------
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Scrub typhus is a mite-borne febrile disease caused by an               
O. tsutsugamushi infection. The disease is endemic in Asian countries and 
the Western Pacific area, the‘Tsutsugamushi Triangle’, with causing an 
estimated one million cases annually1). Recently, scrub typhus has also 
been reported outside of the endemic region, such as in South American 
and African countries. Scrub typhus is a neglected life-threatening disease 
that rivets the attention of missionaries, the military, and medical 
examination committees. Nevertheless, the global incidence of scrub typhus 
is poorly defined due to limited epidemiological data in many of the 
endemic countries2). Given that scrub typhus has been identified as one of 
the major causes of undifferentiated febrile illness, especially in the 
tropical region of Southern Asia3)4)5), there is a raising need for 
epidemiological surveillance of the treatable infection to reduce disease 
morbidity and mortality.
O. tsutsugamushi was isolated in 1930, named for Rickettsia Orientia,  and 
first reported in foreign soldiers in 1951 and 1986 in Korea. In the 1980s 
and 1990s, clinical and epidemiologic features were reported in nearly all 
university hospitals in each province in Korea. However, since 2000, the 
number of patients has increased but the number of clinical studies has 
decreased. The number of reported patients has been steadily increasing, 
the reporting system improving, and physicians’ awareness increasing. 
The number of patients reported to the Korea Centers for Disease Control 
and Prevention increased from 1,000 to 2,000 in the early 2000s then to 
4,698 in 2004. Subsequently, it increased sharply and reached 10,365 in 
2013. The increase in outdoor activity and changes in the use of 
antibiotics may contribute to this change. Further, global warming had 
increased the density of mites, possibly leading to an increase in 
Tsutsugamushi disease.
The natural host for O. tsutsugamushi is the trombiculid mites in which the 
bacterial pathogen has maintained via transovarial or transstadial 
transmission in wild nature8). Since the pathogen is also associated with 
the salivary glands of chigger mites, it could be transmitted to the 
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vertebrate host while the infected mites feed on the tissue and fluid for 
their development. They maintain the infection throughout all of their life 
stages and as adults, and pass the infection on to their eggs in a process 
called transovarial transmission. Similarly, the infection passes from an egg 
to a larva or adult in a process called transstadial transmission. Similarly, 
the infection passes from the egg to the larva or adult in a process called 
transstadial transmission. In this way, chigger mite populations 
autonomously maintain their infectivity over long periods of time. Early 
workers thought that rodents were the natural reservoir of infection, but it 
is now believed that mites are both the vector and the reservoir. Clinical 
scrub typhus is not known to occur naturally in animals. This mite is 
fastidious in matters of temperature, humidity and food, and finds 
everything suitable in restricted areas. Scrub typhus is generally seen in 
people whose occupational or recreational activities bring them into contact 
with ecotypes favorable with vector chiggers. Small rodents and wild birds 
are the primary targets of chigger mites, and humans could be an 
accidental host7). The trigger bite is painless but an eschar often forms at 
the bite site. The disease symptoms are quite variable from mild to fatal 
illness in human infection. Early clinical manifestation of scrub typhus 
should be carefully evaluated with regional lymphadenopathy, followed by 
fever, headache, myalgia, and rashes. Due to a lack of specificity of its 
early clinical presentation compared to other acute febrile illnesses and an 
unavailability of rapid and effective diagnostic tests in local clinics and 
delayed treatment with suitable antibiotics, such as doxycycline and 
chloramphenicol, is common and often leads to severe complications 
including respiratory distress syndrome, acute renal failure, meningitis, 
gastrointestinal tract bleeding and multi-organ failures6)7)8)9). The burden 
of disease is still quite large, accounting for up to 20% of febrile hospital 
admission in rural areas of Southeast Asia, and reaching a mortality rate of 
up to 10% depending on the area of endemicity10)11). Moreover, the 
recurrent infection has often been often observed in the highly endemic 
regions12) potentially due to the antigenic diversity of O. tsutsugamushi13) 
and the failure to generate long-lived immunity after primary infection14).
A single sample with positive IgM antibodies has been associated with an 
acute/primary infection. Due to their long-term persistence in the blood, 
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the presence of IgG antibodies is useful in determining the prevalence of 
scrub typhus in a particular population. Seroconversion or a 4-fold rise in 
IgG titer using paired serum samples (acute and convalescent) better 
supports the diagnosis of scrub typhus15). Early serological assays, 
including the Weil-Felix and the complement fixation (CF) tests have the 
low sensitivity and specificity16). The indirect immunofluorescence assay 
test (IFA) was developed in 1963 in a direct IFA format using Karp and 
Gilliam strains for diagnosis of scrub typhus. The ability of the assay to 
identify the type of scrub typhus using Karp, Kato, and Gilliam strains with 
fluorescent antibodies in a direct IFA format was susequently demonstrated 
17). Karp, Kato, Gilliam,. Litchfield, the Japanese isolates (Irie, Hirano, 
Shimokoshi, Kawasaki, Kuroki, 432h-2, and Yamazaki), Thai isolates 
(TC586, TA678, TA686, TA716, TA763, and TH1817) and Boryong 
strains of O. tsutsugamushi have been used alone or in various 
combinations as antigens with in-house developed IFA assays and/or 
commercial kits18). Immunochromatographic rapid diagnosis tests (ICT) 
have been developed in the last decade following the need for rapid 
diagnosis tools for the diagnosis of scrub typhus. Additionally, the 
enzyme-linked immunosorbent assay (ELISA) using whole-cell antigens of 
Karp, Kato and Gilliam strains of O. tsutsugamushi has been shown to be 
useful for detecting antibodies against new species/strains of              
O. tsutsugamushi outside of the traditional Tsutsugamushi Triangle19)
20)21)22). 
O. tsutsugamushi infections were documented in Myanmar during the 1940s 
and scrub typhus was a major health problem during the Second World 
War II23)24). Since then, however, there have been no reports describing 
the prevalence and genetics of scrub typhus in Myanmar, although recent 
studies conducted on the Thai-Myanmar border identified scrub typhus as 
one of the primary infections causing acute febrile illness. They have also 
reported the recovery of two additional strains of R. orientalis from pools 
of mites collected from bandicoots E. cockerelli in Ramsay  in the Dobadura 
area in New Guinea25).  Umphang, the southernmost district of the Thai 
province of Tak, is situated at the Thai-Myanmar border and lies near the 
central point of the Tsutsugamushi Triangle. Leptotrombidium which 
transmitted O. tsutsugamushi to a host through the bite of an infected mite 
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of the genus can be found in many different types of vegetation (e.g. 
forests, rice paddies, or plantations). Farmers  and people who engage in 
outdoor activities have a higher risk of contracting scrub typhus26)27)28). 
This district is dominated by untouched nature, farmland, and mountainous 
terrain, and more than 90% of the registered population lives in a 
non-urban-environment with the majority of the population engaging in the 
farming industry. Hence, the demography and surrounding environment 
make this district at the Thai-Myanmar border an ideal setting for scrub 
typhus. This area harbors many unregistered people, such as refugees, 
migrant workers, and descendants from hill tribes, entailing a complicated 
humanitarian situation29). Thailand’s Sangkhlaburi District (Kanchanaburi 
Province) is a major gateway on the central part of the Thai-Myanmar 
border where newly arrived migrants from Myanmar become established as 
farm or factory laborers. There, the local Thai people, as well as Karen, 
Mon, and Burmese migrants are commonly bitten by arthropods when 
working in the fields or at home30). These results underscore the need for 
research on the vector-borne infection in this area, including defining the 
genotype diversity of O. tsutsugamushi, which has been a serious obstacle 
for developing effective diagnostic methods and vaccines for scrub typhus.
Huaiyangshan banyangvirus (formerly Severe fever with thrombocytopenia 
syndrome virus (SFTSV)) was first confirmed in China in 2009, and 
retrospective serological studies showed that SFTSV-specific IgM and IgG 
were detected in the sera of patients in China in 1996 and retrospectively 
reported in South Korea in 2010, in Japan in 2013 and Vietnam in 201731). 
Some viruses in China and South Korea were transmitted, likely several 
times, from Japan across the East China Sea and/or the Sea of Japan, and 
vice versa. This fact was also supported by evidence that SFTSV infected 
patients were confirmed in Jeju Island, South Korea, and there were no 
discernible patients  in the Honshu, Shikoku, and Kyusyu islands of Japan, 
which are separated by a sea. At present, there are other possibilities, 
such as the transport of humans and/or livestock accompanied by traveling 
and trade, because the cultural exchanges between China, South Korea, 
and Japan have been active for many centuries. In Vietnam, 2 SFTSV 
infected patients were confirmed in Hue in 2017 by amplifying the partial 
S segment of the viral RNA in stored serum from patients with 
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thrombocytopenia who had elevated levels of serum hepatic enzymes, 
including aspartate aminotransferase and alanine aminotransferase; and 
gastrointestinal symptoms, such as vomiting. H. longicornis, A. 
testudinarium, and I. nipponensis ticks are vectors of SFTSV and         
A. testudinarium has been found in Vietnam. Migratory birds are known to 
be long-distance carriers of virus-bearing ticks. Therefore, virus-bearing 
A. testudinarium ticks and migratory birds may play a role in the dispersal 
of SFTSV to Vietnam. Since then, in Myanmar there have been no reports 
describing the prevalence and genetics of SFTSV. 
SFTSV belongs to the third group of the Phenuiviridae genus, which is a 
member of the Bunyavirales family. The genus Phenuiviridae currently 
includes over 70 antigenically distinct serotypes, 68 of the known 
serotypes are divided into two groups: Phlebotomus fever viruses which 
includes 55 members (transmitted by Phlebotominae sandflies) and the 
Uukuniemi viruses (transmitted by ticks) comprised of 13 members. Only 
eight species (Alenquer, Candiru, Chagres, Naples, Punta Toro, Rift Valley 
fever, Sicilian, and Toscana viruses) cause human diseases. SFTSV has 
been recognized as a novel member of the Phlebovirus genus because it is 
distantly related to both the existing Uukuniemi virus and Phlebotomus 
fever viruses32).  
The clinical course to the SFTS patients could be divided into three major 
stages starting with fever, followed by multi-organ dysfunction, and then 
the convalescent stage. The incubation period ranges between 1 to 2 
weeks, leading to the fever stage which ranges from day 1 to day 7 
post-onset of illness. This stage is characterized in both survivors and 
fatal cases by flu-like symptoms, thrombocytopenia and leukocytopenia, 
and a slight increase in serum biomarkers alanine aminotransferase, 
aspartate aminotransferase, lactate dehydrogenase, creatine phosphokinase, 
and creatine kinase isoenzyme. These symptoms may resolve after 1 week 
in survivors whose serum enzymes begin to decline toward normal levels 
and who then show signs of recovery 2 weeks after the onset of the 
disease. Later, some cases moved on to the multi-organ dysfunction stage, 
where the serum viral load decreased in nonfatal cases but remained high 
in fatal cases, while the platelet counts reverted to a normal value in 
nonfatal cases but continued to decline in fatal cases. In the third stage 
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(over 14 days), nonfatal cases were able to recover from the disease with 
most clinical parameters converting back to normal. In contrast, the fatal 
cases showed increasing serum enzymes accompanied by the main 
complication including multiple organ failure, coagulation, shock, acute 
respiratory distress syndrome, and so on33)34)35).
In the past decades, Phenuiviridae was mainly circulating in some parts of 
Africa and Europe, mainly the Arabian Peninsula, in the regions with the 
highest incidences of the Phlebotomine sandfly transmitted viruses. It 
seems most likely that Phenuiviridae involve arthropod vectors and 
mammalian hosts, including cats, mice, hedgehogs, weasels, possums, and 
yaks. SFTSV is transmitted from adult ticks to larva through ovarian 
transmission. Mammals, such as deer, and cocoons are infected with 
SFTSV through tick bites causing a transit viremia. Ticks acquire SFTSV 
by biting viremic mammals. SFTSV is maintained in nature through the 
close interaction between several species of ticks such as H. longicornis 
and A. testudinarium, and I. Nipponensis and mammals. Humans appear to 
be accidental hosts and play no essential role in the life cycle of SFTSV. 
Some studies indicated that ticks, especially H. longicornis, were the major 
potential insect vector to transmit the virus to humans. Although rodents 
are known as reservoir hosts of Bunyaviruses, there is a pronounced 
discrepancy on SFTSV in rodents. However, the disease can also be 
transmitted from person to person through contact with an infected 
patient’s blood or mucous. SFTSV is a new emerging tick-borne virus 
that can cause hemorrhagic fever with a high mortality of up to 40%. A 
recent molecular evolution analysis suggested that SFTSV originated 20 to 
87 years ago in central China and then was transmitted to other endemic 
countries. Most SFTSV infections occur through bites from the tick H. 
longicornis, although SFTSV transmission can also occur through close 
contact with an infected patient.
Since the first report of SFTSV in humans, the number of human cases 
has rapidly increased each year in China, South Korea, and Japan36)37)38). 
Although the average case fatality rate varies among regions and years 
39), the mean mortality rate of SFTSV cases has remained relatively high 
in Japan (27%), South Korea (23.3%), and China (5.3%-16.2%). No 
vaccines or effective drugs against SFTSV have yet been developed. The 
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severity and clinical outcome of patients infected by SFTSV were 
associated with viral replication and host immune response. Therefore, the 
control strategies for SFTSV are blocking transmission and protecting 
susceptible populations, including protecting against tick bites, avoiding 
direct contact with infectious blood or patients, using personal protective 
equipment when treating patients, and isolating patients and suspected 
clinical SFTSV patients40)41).
Early clinical diagnosis of SFTSV infection is mainly based on the 
patients’clinical manifestations and laboratory tests, such as fever, 
thrombocytopenia (and/or leukopenia), and elevated levels of liver 
enzymes, and epidemiological characteristics including the history of a tick 
bite, living and working environments and epidemic season42)43). 
Confirmation of SFTSV infection requires one of the following conditions: 
isolation of SFTSV from the patients’samples, detection of SFTSV RNA in 
the patients’blood or serum, or detection of SFTSV-specific antibodies in 
the patients’serum. Virus isolation is often the most confident evidence 
for virus infection, and SFTSV could only cause CPE on DH82 cells, but 
not on Vero cells or Vero E6 cells in primary isolation, which may be why 
isolation of SFTSV has failed for such a long time in China44). This 
method is mainly used in research institutions, however, the work is 
always very time and energy-consuming, so that the other two strategies 
are often applied in clinical confirmation assays. Commonly, the viral 
nucleic acids can be detected in the acute phase serum of patients, within 
2 weeks post-onset of the disease. Several methods have been developed 
to amplify the viral RNA, including reverse transcription loop-mediated 
isothermal amplification (RT-LAMP). Recently, a method that incorporates 
RT-cross-priming amplification (RT-CPA) coupled to a vertical-flow 
visualization strip has been developed for the rapid detection of SFTSV, 
which is even more simple and near-instrument-free, and very practical 
for point-of-care testing45)46)47). Several serological tests have been used 
to detect antibodies against SFTSV. Double antigen sandwich ELISA, in 
house Mac-ELISA and indirect ELISA assays were developed to detect 
SFTSV specific total, IgM, and IgG antibodies in serum samples, 
respectively48). The indirect immune-fluorescence assay is also used to 
test the virus-specific antibodies from SFTSV infected cells or tissues, 
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which is often used for confirmation of virus infection and observation of 
infectious status49). 
Mixed infection with SFTSV and O. tsutsugamushi has been detected in 
South Korea where both pathogens are endemic. These results further 
emphasize the urgent need for an epidemiological study on the 
vector-borne diseases in the area of endemicity to improve our stability to 
accurately differentiate and properly treat these febrile infectious diseases 
with atypical signs and symptoms during the initial stage50). The clinical 
presentations of SFTSV and scrub typhus are similar during the early 
stage of infection: signs and symptoms typically develop within 1 and 2 
weeks of infection and include fever, headache, malaise, and 
gastrointestinal symptoms, but SFTS exhibits a higher mortality rate than 
scrub typhus51). In South Korea, SFTSV and scrub typhus are endemic and 
are major public health concerns between May and November and between 
October and November, respectively. Mixed infections with SFTSV and O. 
tsutsugamushi in a patient have been reported.
SFTSV and O. tsutsugamushi are often neglected tropical diseases bearing 
similar seasonal patterns and rodents as a common reservoir. Their 
common epidemiology creates an opportunity for dual infections. Although 
SFTSV and O. tsutsugamushi do not share a specific vector, they are 
transmitted to humans through tick and mite bites mostly, respectively, 
during outdoor activities. The ecological differences between vectors may 
characterize their epidemiological features, including the region of infection 
and peak epidemic seasons. However, there are considerable overlaps of 
their epidemiological and clinical features, which makes their differential 
diagnosis difficult, particularly during the high epidemic season of scrub 
typhus. A high index of suspicion by primary physicians is needed in 
patients of endemic regions presenting with acute febrile illness, myalgia, 
or a rash which may be suggestive of coinfection with scrub typhus and 
SFTS.  
In this study, I provide retrospective evidence of SFTSV infections or 
mixed infection with O. tsutsugamushi in patients’sera collected in South 
Korea from 2000 to 2003. These findings confirmed that SFTSV infections 
in South Korea occurred earlier than reported in South Korea and Japan 
and were more concurrent with those in China. Considering SFTSV 
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infection in patients with scrub typhus is also important for clinical 
diagnosis.
I investigated the serological prevalence and genotypic diversity of       
O. tsutsugamushi using blood samples from suspected scrub typhus 
patients in Myanmar. I also searched for possible infection of SFTSV 
which has been a new emerging threat to public health in Eastern Asia. 
My current serological and molecular survey on these vector-borne 
infections revealed that scrub typhus is highly prevalent even in young 
children and is caused by various genotypes of O. tsutsugamushi, including 
Karp, Kato, Gilliam, and JP genogroups in Myanmar. Moreover, detection of 
SFTSV infection, as well as potential coinfection with scrub typhus, in the 
Myanmar patients suggests that SFTSV infection may have a much wider 




The study in Korea was approved by the Institutional Review Board of 
Seoul National University Hospital. Study in Myanmar was approved by the 
ethics review committee of the Department of Medical Research, Ministry 
of Health and Sports in Myanmar (Ethics/DMR/2018/134), and the 
institutional review board of Seoul National University Hospital (IRB 
1910-057-1069).  
2. Subjects and sample collection
I examined 2,328 sera samples of patients from 2000 to 2003 for the 
diagnosis of rickettsial disease at Seoul National University, Seoul, South 
Korea. The patients suffered from an acute febrile illness from November 
1, 2000, to November 1, 2003. In Myanmar, whole blood samples were 
collected from clinically suspected scrub typhus patients admitted to local 
hospitals in Sagaing and Magway provinces between February 2018 and 
January 2009. Specimens collected from 152 patients were transported to 
the University of Medicine 1 (Yangon, Myanmar) to prepare sera and 
stored at –80oC until use in Seoul National University.
3. Antibodies and reagents
Anti-NP (SFTS virus) (Huaiyangshan Virus) (IT-017-006M11)(Immune 
Technology, New York, USA). Anti-NP antibody produced from Rabbit 
(Polyclonal antibody production Service in Abclon, South Korea). 
Horseradish peroxidase (HRP)-conjugated anti-mouse, anti-human IgG 
secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, California, 
USA) were used for immunoblotting and HRP-conjugated anti-mouse 
IgG1, IgG2c (Santa Cruz Biotechnology) were used for ELISA. The Alexa 
Fluor 488 or Alexa Fluor 594-conjugated anti-mouse and human 
antibodies used in the immunofluorescence assays were purchased from 
Molecular Probes (Invitrogen, Carlsbad, California, USA). For the focus 
forming assay, methyl cellulose was purchased from Sigma (Madison, 
Wisconsin, USA) (M0387-100G). HiSenScript TM RH (-) RT-PCR 
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Pre-Mix was used in Reverse Transcription PCR process, synthesizing 
cDNA from RNA of SFTSV, followed by amplifying cDNA products by PCR 
process (AccuPower R Pfu PCR Premix, K-2024, Bioneer, South Korea). 
To amplify the tsa56 gene of O. tsutsugamushi using a set of primers 
(forward primer: GATCAAGCTTCCTCAGCCTACTATAATGCC, reverse 
primer: CTAGGGATCCCGACAGATGCACTATTAGGC). To amplify the NP gene 
of SFTSV using set of primers: forward primer: ATCGTCAAGGCATCAGGGAA, 
reverse primer: TTCAGCCACTTCACCCGAA).
4. Cell culture
L929 cells (ATCC; NCTC929), Vero cell (ATCC CCl-81) were maintained 
in Dulbecco’s Modified Eagle’s Medium (DMEM, Welgene, Daegu, South 
Korea) supplemented with 10% heat-inactivated fetal bovine serum (FBS) 
(Welgene), 100 U/mL penicillin and 100 U/mL streptomycin (Gibco BRL, 
Gaithersburg, Maryland, USA) at 37OC in 5% CO2.
5. Preparation of Orientia tsutsugamushi and amplification of nucleic acids
The Boryong, Karp, Kato, and Gilliam strain of O. tsutsugamushi were 
propagated in L929 cell. At 3 to 4 days post-infection, infectivity was 
determined using an indirect immunofluorescence assay. When an infection 
rate of >90% was achieved, the cells were harvest by centrifugation at 
1000 Х g, 10 minutes, 4
oC. Infected L929 cells were harvested, washed 
with phosphate-buffered saline (PBS, pH 7.2), spotted onto spot slides, 
and fixed with cold acetone for 10 minutes. The slides were stored at 
–70oC until used. 
Total DNA or viral RNA in sera was extracted using DNeasy Blood and 
Tissue kit or QIAamp viral RNA Mini kit (QIAGEN, Germany), 
respectively, according to the manufacturer’s instruction. For molecular 
diagnosis of O. tsutsugamushi, polymerase chain reaction (PCR) was 
performed to amplify the tsa56 gene of O. tsutsugamushi using a set of 
primers (forward primer: GATCAAGCTTCCTCAGCCTACTATAATGCC, 
reverse primer: CTAGGGATCCCGACAGATGCACTATTAGGC). To detect 
SFTSV RNA, Reverse transcription PCR (RT-PCR) was performed to 
amplify the partial small (S) segment of the viral RNA from the patients’ 
sera and confirm SFTSV infection. SFTSV mRNA was extracted from the 
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patients’sera using TRIzol reagent (Promega, Madison, USA). mRNA was 
then subjected to reverse transcription using HiSenScript TM RH(-) 
RT-PCR Pre-mix, synthesizing cDNA from RNA of SFTSV, followed by 
amplifying cDNA products by PCR process (AccuPower R Pfu PCR Premix, 
K-2024, Bioneer) to amplify the NP gene of SFTSV using a set of NP 
gene-specific primers. The PCR products were sequenced using the 
BigDye Terminator Cycle Sequencing Kit (Perkin Elmer Applied 
Biosystems, Warrington, UK). 
6. TA cloning 
Taq DNA polymerase (Bioneer) is used to amplify the DNA fragment in 
PCR process with a set of primers tsa56 gene of O. tsutsugamushi under 
the following conditions: denaturation for 10 minutes at 94oC, followed by 
30 cycles of denaturation for 30 seconds at 94oC, annealing 30 seconds at 
63oC, an extension for 1 minute at 72oC and after 30 cycles, an extension 
for 7 minutes at 72oC. The DNA ligation step was followed by a 
manuscript by pGEM®-T Easy Vector System I kit (Promega). 1 µl of 
ligated using T4 DNA Ligase was transformed into 100 µl E. coli 
(Escherichia coli) (TOP10- Cat no. C4040-10, Invitrogen, Waltham, MA 
USA) cells and incubated on ice for 30 minutes. A 42OC heat-shock of 45 
seconds was performed, followed by immediate placement on ice for 10 
minutes. 500 µl of LB media (Luria-Bertani (broth)) (Affymetrix/ USA 
Agar, Waltham, Massachusetts, USA) were added to the bacterial 
suspension before incubating at 37oC for 1 hour. The entire aliquot was 
plated out on 1.5% (w/v) LB Agar plates with 100 µg/ml ampicillin and 
incubated overnight at 37oC. Colonies of E. coli were isolated from 
commercial sources through plating on LB agar (Affymetrix/USA Agar). 
Single colonies were isolated into 2 ml of relevant media overnight. 
Extract DNA from E. coli culture by LaboPass Plasmid kit Purification Kit 
(COSMO Genetech, South Korea).
7. Cloning, expression, and purification of proteins.
The synthesized NP gene was then cloned into a pET28a vector (Novagen, 
Gibbstown, New Jersey, USA) for sequence analysis and protein 
expression. For the expression and purification of NP proteins, the gene 
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containing pET-28a constructs were transformed into E. coli BL21 (DE3) 
strain (RBC Bioscience Co., Taipei, Taiwan). The strain was grown into 
LB broth supplemented with 50 µg/ml kanamycin at 37oC  overnight. 
Cultures were inoculated in fresh LB broth and grown at 37oC until the 
optical density at 600 nm (OD600) reach to 0.5. Protein expression was 
induced by adding 0.1 mM isopropyl-D-thiogalactoside (IPTG; Duchefa, 
Zwijndrecht, Netherlands) for 16 hours at 16oC. Bacteria were harvested 
by centrifugation at 1,000 Х g for 10 minutes, resuspended in binding 
buffer (300 mM NaCl, 50 mM sodium phosphate buffer) containing 1 
mg/ml of lysozyme, incubated at 4oC for 30 minutes, and disrupted by 
sonication on ice for 5 minutes. The sonicated lysates were centrifuged at 
1600 Х g for 20 minutes at  4
oC and the supernatants applied to a 
Ni-nitrilotriacetic acid (NTA) His-resin (Qiagen). His-tagged proteins 
bound to the Ni-NTA resin were eluted with elution buffer (300 mM 
NaCl, 50 mM sodium phosphate buffer, 250 mM imidazole) and serially 
dialyzed against elution buffer to remove any free imidazole. The identity 
and purity of proteins were assessed by Western Blotting and Coomassie 
Blue staining, respectively.
8. Immunofluorescence microscopy
Immunofluorescence microscopy was used to visualize O. tsutsugamushi. 
After seeding O. tsutsugamushi infected L929 cell in the Diagnostic 
microscope slides and fix, permeabilized by Acetone, within 15 minutes. 
Incubated with pooled scrub typhus human serum for 1 hour at room 
temperature, followed by incubation with Alexa Fluor 488-conjugated goat 
anti-mouse IgG and Alexa Fluor 594-conjugated mouse anti-rabbit IgG 
(Invitrogen, Carlsbad, California, USA). Seroconversion IgG observed with 
immunofluorescence assay using O. tsutsugamushi and patients’sera were 
started from 1:40, 4 fold increase, a serial dilution of patients’sera titer. 
Images were analyzed and processed using the Olympus Fluoview software 
(Olympus, Tokyo, Japan). 
9. Enzyme-linked immunosorbent assay (ELISA)
To scan the positive patient sample or determine the antibody titers, 
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immunoassay plates (96-well plates; Nunc, Rochester, New York, USA) 
were coated with 100 µl of purified antigen at a final concentration of 1 
µg/ml at 4oC overnight. The plates were then blocked for 2 hours at room 
temperature with PBS containing 5% skim milk. 100 µl of serum samples 
serially diluted in 2-fold were incubated at room temperature for 2 hours. 
After washing with PBS containing 0.05% Tween 20 (0.05% PBST), 100 
µl of 1:10,000 diluted HRP-conjugated mouse anti-human IgM, total IgG 
(Southern Biotechnology Associates, Birmingham, Alabama. USA) was 
added and incubated at room temperature for 1 hour. Wells were washed 
with 0.05% PBST and incubated with 3,3,5,5’ -tetramethylbenzidine 
(TMB) peroxidase substrate solution (KPL, Gaithersburg, Maryland, USA) 
for 10 minutes. The reactions were stopped by addition of 1 M phosphoric 
acid (H3PO4) solution. Absorbance was measured at 450 nm using a 
microplate reader (Beckman Coulter Inc., Fullerton, California, USA). 
Specific human IgG against NP protein was tested with investigated 
patients’samples from one fixed dilution factor (1:100) of serum. The 
x-axis indicates the number of patient serum, and the y-axis indicates the 
optical density (O.D.) at 450 nm. The cutoff values are calculated following 
the formula of the form“mean + 3 standard deviation of negative 
controls” 
10. Focus forming assay
SFTSV stock was diluted in 10-fold increments, and each dilution (200 µl) 
was inoculated onto a monolayer of Vero cells in 24-well plates. After 
incubating for 1 hour at 37oC, the suspension was removed from each well, 
and each well was over-aid with 1 ml of 1% methyl cellulose solution. 
The cells were cultivated for 7 days in a 37oC incubator with 5% CO2. 
The methyl cellulose overlay was removed from each well, and the 
monolayers were fixed with methanol-acetone (1:1) (1 ml) for 30 
minutes. After washing 3 times (15 minutes/time) with phosphate-buffered 
saline (PBS), the monolayers were blocked with 3% Bovine Serum 
Albumins in PBS for 1 hour and were incubated for 1 hour with an 
anti-NP antibody against SFTSV or patient serum with serial dilution 
factor from 1:10 to 1:640. After washing 3 times with PBS, the 
monolayers were incubated for 1 hour with 1:500 Alexa Fluor 
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594-conjugated anti-Human and Alexa Fluor 488-conjugated anti-rabbit 
antibodies used in the immunofluorescence assays were purchased from 
Molecular Probes (Invitrogen, Carlsbad, California, USA). Images were 
analyzed and processed using the Olympus Fluoview software.
11. Immunochromatography test (ICT)
Immunochromatography test (ICT) strips containing TSA56 and ScaA 
antigens from O. tsutsugamushi Boryong, Gilliam, and Karp genotypes were 
manufactured (Bore Da Biotech Co., Seongnam, South Korea) and tested 
for rapid diagnosis of scrub typhus according to the manufacturer’s 
instruction. Results were visualized in 15 minutes after loading mixtures of 
a chasing buffer (200 µl) containing gold particles and 50 µl of patient 
serum on a sample pad. Representative images of ICT results detect 
specific IgG against TSA56 and ScaA antigen in suspected scrub typhus 
patients’sera. The red band appearing on the control line (C) and test 
line (T) including TSA56 and ScaA line concurrently or either way was 
regarded as positive. The test was considered as negative when only the 
control band appeared as red. And if no band appeared on the control line, 
then the test was considered invalid. 
12. Sequence analysis
Severe fever with thrombocytopenia syndrome virus is isolated from 
patient serum (GenBank accession no. MN329148.1). Sequence information 
for NP genes was found in the genomes of SFTSV strains (GenBank 
accession no. KP663733.1). Genetic and phylogenetic analyses were 
conducted by aligning published sequencing of SFTSV obtained from China, 
Japan, and South Korea, Vietnam. In order to estimate and compare the 
degree of genetic diversity of tsa56 genes with other O. tsutsugamushi 
genes, I collected 17 bacterial genes including the tsa56 genes (1) 
reference) from two complete genome sequences (Boryong, and Ikeda strain 
and seven draft genomic contigs (strain Bio project accession no; Gilliam: 
PRJNA212442, Karp: PRJNA212456, Kato: PRJNA212440, TA716: 
PRJNA212457, TA763: PRJNA212454) available in Bioproject 
(http://www.ncbi.nlm.nih.gov/bioproject). 
Multiple sequence alignment was performed using the ClustalW algorithm in 
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MEGA version 6.0. Phylogenetic analyses were performed based on the 
complete sequence of the S segment of SFTSV using the maximum 
likelihood (ML) method based on Kimura’s 2-parameter model. The 




1. Severe fever with thrombocytopenia syndrome virus jnfection or mixed 
jnfection with scrub typhus in South Korea 2000-2003
I examined 2,328 sera samples collected from patients who suffered from 
an acute febrile illness presenting from November 1, 2000, to November 1, 
2003, for the diagnosis of Rickettsia disease at Seoul National University, 
South Korea.
1.1. Analysis of SFTSV NP-specific antibody response by ELISA method
2,328 samples were tested for IgM and IgG antibodies against 
SFTSV-specific NP protein by ELISA method. There were no samples in 
which SFTSV NP-specific IgM antibodies could be detected. SFTSV 
NP-specific IgG antibodies were detected in the sera of 37 patients 
(37/2,328, 1.6%) (Figure 1). In the year 2000, there were 8 samples 
(8/400, 2.0%) positive for the SFTSV NP-specific IgG antibody. In the 
year 2001, among 188 tested samples, 3 samples (3/188, 1.5%) were 
positive for the SFTSV NP-specific antibody. In the year 2002, 12 
samples (12/441, 2.7%) detected the SFTSV NP-specific antibody. In the 
year 2003, there were 14 patients’ sera (14/1,299, 1.1%) which tested 
positive for the SFTSV NP-specific antibody response (Figure 1) (Table 
2).
  
1.2. Baseline characteristics of patients positive with IgG against 
SFTSV-specific NP protein 
In 37 patients’ sera positive for the SFTSV NP-specific antibody 
response via the ELISA method, the mean age was 61.07±14.1 years. 
Both groups aged from 21 to 30 years old and 31 to 40 years old had 1 
patient (1/37, 2.7%). 5 patients (5/37, 13.5%) were aged 41 to 50 years 
old. The group aged 51 to 60 years old had 7 patients (7/37, 18.9%). The 
over 60 year-old group included the highest number of patients at 14 
patients (14/37, 37.8%) (Table 1) (Figure 2). The 37 tested patients 
included 10 males (10/37, 37.03%) and 27 females (27/37, 72.97%). 9 
samples (9/37, 24.0%) had no information about the age and gender 
(Table 1) (Figure 2). The seasonal distribution of 37 patients’ sera 
positive for the SFTSV NP-specific IgG antibody was obvious. The month 
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with the highest number of patients testing positive for the SFTSV 
NP-specific antibody was November with 25 samples (25/37, 67.5%). In 
October and December, there were 5 positive samples (5/37, 13.5%) and 
3 positive samples (3/37, 8.1%), respectively. The remaining months have 
1 positive sample or no positive samples (Table 1) (Figure 2). In hospital 
records, by IFA method, some samples were positive with Hantavirus 
which caused Hemorrhagic fever and renal syndrome (HFRS), Leptospira 
which caused Leptospirosis, and R. typhi which caused murine typhus. 
Among the 37 tested samples, one sample tested positive for Leptospira 
and 4 samples tested positive for R. typhi (Table 1). Two samples (2/37, 
5.4%) tested positive for SFTSV and R. typhi (≥1:1,280) in 2001. There 
was 1 sample (1/37, 2.7%) that tested positive for SFTSV and           
O. tsutsugamushi (≥1:2,560) and Leptospira (≥1:160), and 1 sample 
(1/37, 2.7%) that tested positive for SFTSV and O. tsutsugamushi 
(≥1:2,560) and R. typhi (≥1:160) in 2002. There was 1 sample (1/37, 
2.7%) that tested positive for SFTSV and R. typhi (≥1:80) in 2002. 
1.3. Detect SFTSV-specific IgG antibody in patients’ sera
All samples positive for the SFTSV NP-specific IgG antibody via the 
ELISA method were confirmed through staining SFTSV plaque by 
immunofluorescence assay (IFA). Among the 37 samples, SFTSV 
NP-specific IgG antibodies were detected in the sera of 15 samples 
(15/37, 40.5%). In the year 2000, among the 8 samples positive for the 
SFTSV NP-specific IgG antibody via the ELISA method, there were 6 
samples (6/8, 75.0%) that tested positive via the IFA method. In the year 
2001, no samples could detect the SFTSV NP-specific IgG antibody. 
Otherwise, there were 2 samples (2/3, 66.6%) that tested positive for    
R. typhi via the IFA method. In the year 2002, 3 out of the 12 patients’ 
sera (3/12, 25.0%) that tested positive via the ELISA method were 
detected with the SFTSV NP-specific IgG antibody. Among the 12 tested 
samples in 2002, 1 sample (1/12, 8.3%) and 2 samples (2/12, 16.6%) 
were positive for the Leptospira-specific antibody and R. typhi-specific 
antibody, respectively via IFA.  In the year 2003, 6 of the 14 samples 
(6/14, 42.9%) carried titers (≥1:160) of IgG antibodies specific to 
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SFTSV, as measured via IFA (Figure 3) (Table 2).
1.4. Detection of SFTSV-specific NP gene by RT-PCR from the patients’ 
sera and the phylogenetic tree constructed based on partial S segment 
sequences of SFTSV
To detect the SFTSV-specific NP gene by RT-PCR from the patients’ 
sera, I screened 37 patients’ whose sera was positive for the SFTSV 
NP-specific antibody response in South Korea from 2000-2003. The 
SFTSV-specific NP gene was detected in the sera of 9 samples (9/37, 
24.3%) among the 37 positive samples from the ELISA method (Figure 4). 
In the year 2000, 2 samples (2/8, 25.0%) were clearly positive for the 
SFTSV-specific NP gene RNA. In the year 2001, 1 out of the 3 patients’ 
sera (1/3, 33.3%) that tested positive from the ELISA method was 
detected with the SFTSV-specific NP gene. In the year 2002, 12 
patients’ sera were positive with IgG antibodies against SFTSV via 
ELISA. Among them, there were 5 samples (5/12, 41.7%) which detected 
the SFTSV-specific NP gene. In the year 2003, 6 samples (6/14, 42.9%) 
were clearly positive for the SFTSV-specific NP gene RNA. The 
percentage of patients’ sera which detected the SFTSV-specific NP gene 
had rapidly increased each year from the years 2000 to 2003. The 
percentage of positive samples in the year 2000 was 25.0%. In the year 
2001, the percentage of positive samples was up to 33.3% of patients. 
This percentage in the years 2002 and 2003 dramatically increased to 
41.7% and 42.9%, respectively (Table 2). The partial S segment 
sequences of SFTSV were detected in 9 patients (9/37, 24.3%) via two 
rounds of RT-PCR, and the resulting phylogenetic tree of the partial S 
segment compared to 19 proto-genotypes showed that the partial S 
segment’s isolates were similar to those from China, South Korea, and 
Japan. Among the 9 positive samples, there were 5 isolated samples which 
differed by only one base from the other 4 isolates, suggesting genetic 
homogeneity of SFTSV in South Korea (Figure 5).
1.5. The presence of antibody response specific for O. tsutsugamushi in 
patients’ sera
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37 patients’ sera positive for the SFTSV NP-specific IgG antibody via 
ELISA were tested for IgG antibodies against O. tsutsugamushi using IFA. 
O. tsutsugamushi-specific IgG antibodies were detected in the sera of 17 
patients (17/37, 45.9%) (Figure 6) (Table 2). In the year 2000, there 
were 4 samples (4/8, 50%) that tested positive for the O. 
tsutsugamushi-specific IgG antibody via IFA. In the year 2001, among 3 
samples tested, 1 sample (1/3, 33.3%) was confirmed for the presence of 
the O. tsutsugamushi-specific IgG antibody in the patients’ sera. In the 
years 2002 and 2003, there were 4 samples (4/12, 33.3%) and 8 samples 
(8/14, 66.7%) in which antibody response specific to O. tsutsugamushi was 
detected, respectively. Among all patients’ sera positive for the SFTSV 
NP-specific antibody via the ELISA method, 45.9% of samples detected 
the O. tsutsugamushi-specific IgG antibody. Sometimes patients had a 
primary infection, the initial infection caused by one pathogen such as 
SFTSV or O. tsutsugamushi which can continue with a secondary infection 
by a different pathogen (SFTSV or O. tsutsugamushi). It was considered 
as an evidence for potential coinfection with the two pathogens            
O. tsutsugamushi and SFTSV.
1.6. Amplification of O. tsutsugamushi-specific tsa56 gene by PCR from 
the patients’ sera and the phylogenetic tree constructed based on the   
O. tsutsugamushi-specific tsa56 gene sequences
For the molecular diagnosis of scrub typhus, all of the ELISA samples 
positive for SFTSV were examined by PCR to confirm the                
O. tsutsugamushi infection and identify the genotypes of O. tsutsugamushi 
in South Korea from November 1, 2000, to November 1, 2003. By PCR 
process, the O. tsutsugamushi-specific tsa56 gene was detected in 14 
patients (Figure 7). Among these 14 patients, 12 patients belonged to the 
group aged 50 and over, only 1 patient was 47 years old, and 2 patients 
lacked information about age. After direct DNA sequencing of PCR 
products, among the samples 14 were detected to have the tsa56 gene. 
Nine samples showed a clear genotype of O. tsutsugamushi with the 3 
genotypes Karp_C (6/37, 16.2%), Boryong (1/37, 2.7%), Gilliam (2/37, 
5.4%). Five samples showed a mixed-infected O. tsutsugamushi strain 
(5/37, 13.5%). By TA cloning, I was only capable of classifying strains 
- 27 -
isolated from the mixed-infected O. tsutsugamushi in 2 samples, both of 
which were mixed between the Karp and Gilliam strains (Figure 8). Three 
mixed samples could not be classified by O. tsutsugamushi genotypes. 
Phylogenetic analysis of the 15 samples detected the tsa56 gene by 
comparison with the sequences from 16 proto-genotypes which revealed 
Boryong (1/37, 2.7%), Karp_C (8/37, 21.6%) and Gilliam (4/37, 10.8%) 
(Figure 8). The surveillance for the 37 positive samples from South Korea 
from 2000-2003 showed that Karp_C (21.6%) is more abundant compared 
to the other detected genotypes Boryong (2.7%) and Gilliam (10.8%).  
1.7. Potential coinfection with O. tsutsugamushi and SFTSV
Based on the results of the molecular detection of the two pathogens       
O. tsutsugamushi and SFTSV, there were 4 samples (4/37, 10.8%) which 
detected both the presence of the O. tsutsugamushi-specific tsa56 gene 
and SFTSV-specific NP gene, considering the potential coinfection with   
O. tsutsugamushi and severe fever with thrombocytopenia syndrome virus 
(SFTSV) (Table 3). One sample was collected from the year 2000 and 
three samples were collected from the year 2003. Four samples showed 
potential coinfection with 2 kinds of the pathogen which were all classified 
under 2 genotypes of O. tsutsugamushi Karp and Gilliam. Among 37 
patients’ sera positive with an SFTSV NP-specific antibody response, 15 
patients’ sera (15/37, 40.5%) showed a positive result by staining an 
SFTSV plaque (≥1:160). Five samples (5/37, 13.5%) were positive for 
both pathogens O. tsutsugamushi and SFTSV via IFA method with titer 
≥1:1,280 and ≥1:160, respectively (Table 3). Two samples were 
collected from 2000, 1 sample was collected from 2002, and the remaining 
sample was collected from 2003. There were 5 samples (5/37, 13.5%) 
which showed potential coinfection between 2 pathogens by detecting the 
SFTSV-specific NP gene and O. tsutsugamushi-specific IgG antibody. One 
sample tested positive for the O. tsutsugamushi-specific IgG antibody with 
titer ≥1:1,280 and was collected in 2003. Four remaining samples were 
collected in 2003 with antibody titer ≥1:80 specific for O. tsutsugamushi. 
Among the 37 samples, 4 samples (6/37, 16.2%) were positive for the 
SFTSV-specific antibody and which also detected the O. 
tsutsugamushi-specific tsa56 gene. One sample with potential coinfection 
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with O. tsutsugamushi and SFTSV was collected in the year 2000, 1 
sample was from the year 2002, and the 4 remaining samples were all 
collected in the year 2003.
2. Genotype diversity of O. tsutsugamushi in scrub typhus patients and 
coinfection with severe fever with thrombocytopenia syndrome virus in 
Myanmar
I analyzed 152 sera collected from suspected scrub typhus patients 
admitted to local hospitals in the Sagaing and Magway provinces, located in 
the central part of Myanmar (Figure 9). There were 129 patients’ sera 
from Sagaing (129/152, 84.8%), and the 23 remaining samples were 
collected from Magway (23/152, 15.2%). This study was conducted in two 
phases. In phase 1, all patients fulfilling the inclusion of the criteria 
patients of acute undifferentiated fever (AUF) were recruited. This formed 
the sampling frame for identifying study participants for this study. Phase 
2 of the study wherein all patients of AUF which were found positive for 
the O. tsutsugamushi and SFTSV pathogen were included for further 
evaluation. 
2.1. Baseline characteristics and the results of serological and molecular 
diagnosis of patients’ samples in Myanmar
The baseline characteristics of the patients were summarized in Table 4. 
All of the patients with acute undifferentiated fever were successfully 
treated in the local clinics and recovered from febrile illness. The mean 
age of the suspected scrub typhus patients was 27±19.8 years old and 
ranged from 2 to 73 years old. The standard deviation of the suspected 
patients is 19.8, which is large, showing the large variety of suspected 
patients’ ages. Scrub typhus disease was suspected the most in patients 
who were under 10 years old (38/152, 25.0%), and from 11 to 20 years 
old with a fever duration of 4.57±1.5 days  and 5.8±2.6 days, 
respectively. There were 23 patients aged from 21 to 30 years old 
(23/152, 15.1%) with a fever duration of 6.1±2 days. Ten patients 
(10/152, 6.6%) were aged 31 to 40 years old, and patients over 61 years 
old, had a fever duration of 5.8±2.7 days, and 9.9±4.8 days, respectively. 
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There were 17 patients aged 41 to 50 years old (17/152, 11.2%) with a 
fever duration of 7.4±2.8 days. The patient population aged 51 to 60 of 
16 people (16/152, 10.5%) with a fever duration of 6.6±3.12 days. One 
patient had no information about the fever duration (Table 4) (Figure 10). 
93 suspected patients (93/152, 61.2%) were male, almost double that of 
female patients. The male group had a fever duration of 6±2.9 days, and 
the female group had a fever duration of 6.2±2.9 days. Eschar was 
observed in 144 patients (144/152, 94.7%) and the mean fever duration 
was 6 days (S.D.:±2.9 days), Nine patients (9/152, 5.9%) could not 
observe eschar, 3 of which were under 10 years old, 3 of which were 
from 10 to 20 years old, and 3 of which were 20 to 50 years old. 25 
suspected patients (25/152, 16.4%) had muscle and joint pain (myalgia) 
with the mean age being 36.4±14.7 years. Six patients (6/152, 3.9%) 
lacked information about myalgia symptoms. The rash symptom was 
observed in 3 patients (3/152, 2.0%) from 20 to 40 years old. Among 3 
patients with a rash, 2 suspected patients also had eschar, and 1 
suspected patient had myalgia and rash but no eschar. There were 8 
patients (8/152, 5.26%) only having fever but could not observed as 
having eschar, myalgia, and rash with a fever duration of 7±1.5 days 
(Table 4).
2.2. Diagnosis test specific for SFTSV in 152 patients’ sera and the 
phylogenetic tree constructed based on partial S segment sequences of 
SFTSV
Among the 152 patients’ sera, samples positive with the SFTSV-specific 
antibody were confirmed by staining SFTSV plaque with 
immunofluorescence assay (IFA). There was only 1 patient’s serum 
(1/152, 0.65%) which tested positive for a SFTSV-specific antibody 
response (≥1:40) with a fever duration of 8 days, and a mean age of 33 
years old (Figure 12). The positive patient had both eschar and myalgia 
(Table 5). Finally, I investigated for potential infection with SFTSV in 
Myanmar patients via RT-PCR analysis. Among the 152 patients’ sera, 5 
sera (5/152, 3.3%) were positive for the partial S segment of the SFTSV 
RNA genome, indicating SFTSV infection. It is also interesting to note that 
4 out of the 5 positive patients had eschar and 4 of the 5 patients  were 
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under 15 years of age (Table 5). A phylogenetic analysis of the partial S 
segment sequences compared with 40 proto-genotypes showed that 4 
isolates were the same as those previously reported from Vietnam, and 
one isolate differed by one base from the other 4 isolates (Figure 13), 
suggesting genetic homogeneity of SFTSV in Southern Asia.
2.3. Initial serological diagnosis of patients’ sera in 152 samples in an 
immunochromatography test (ICT)
The initial serological diagnosis of 128 sera using immunochromatography 
test (ICT) strips coated with TSA56 revealed 36 patients’ sera (36/128, 
28.1%) testing positive for the O. tsutsugamushi TSA56-specific IgG 
antibody, with a fever duration of 6.7±3.35 days. ICT strips coated with 
ScaA have revealed 25 patients’ sera (25/128, 19.5%) positive for the  
O. tsutsugamushi ScaA-specific IgG antibody, with a fever duration of 
5.8±2.8 days. 20 patients’ sera (20/128, 15.6%) reacted with both 
antigens TSA56 and ScaA specific for O. tsutusgamushi (Figure 14) 
(Table 5). Among all of the positive patients’ sera from the ICT strips, 
there were no samples in which tsa56 gene sequences could be detected. 
Moreover, the overall positive rate of the home-made ICT was relatively 
low (41/128, 32%) when compared to the IFA detecting IgG responses 
against the bacterial antigen (101/128, 78.9%).
2.4. The presence of antibody response specific for O. tsutsugamushi in 
patients’ sera
To confirm serological possibility against the bacterial antigen, I also 
conducted IFA using cells infected with O. tsutsugamushi, the gold 
standard method for diagnosis of scrub typhus (Figure 15). Among 152 
patients’ sera, 119 (119/152. 78.3%) samples were positive (≥1:40) for 
the O. tsutsugamushi-specific IgG antibody, with a fever duration of 
6.2±3.2 days, and 90 samples (90/152, 59.2%) were positive for the    
O. tsutsugamushi-specific IgM antibody, with a fever duration of 6.4±3.2 
days (Table 5). There were 69 patients’ sera (69/152, 45.3%) which 
were positive for both the O. tsutsugamushi-specific IgG and IgM 
antibodies. Median titers of the positive sera were 1:640 for both the IgG 
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and IgM antibodies (Figure 15) (Table 5). 13 patients‘ sera (13/152, 
8.6%) among the suspected scrub typhus samples were negative for both 
the IgG and IgM antibodies against the bacterial pathogen. Eschar was 
observed in all 13 of these samples. In the case of suspected scrub typhus 
patients with no eschar, 3 patients‘ sera (3/152, 1.97%) were positive 
for both specific IgG (≥1:40) and IgM (≥1:160), 6 samples were positive 
for specific IgG (≥1:160), and 1 sample was positive for specific IgM 
(1:160) (Figure 15). 
2.5. Amplification of O. tsutsugamushi-specific tsa56 gene by PCR from 
the patients’ sera and the phylogenetic tree constructed based on the O. 
tsutsugamushi-specific tsa56 gene sequences
For the molecular diagnosis of scrub typhus, all of the samples were 
examined by PCR to confirm infection and identify the genotypes of      
O. tsutsugamushi in the Myanmar patients. Among the 152 sera, I could 
detect specific PCR products from 9 tsa56 gene sequences by a 
comparison with sequences from 17 proto-genotypes which revealed the 
presence of at least five genotypes: Karp A (4/9, 44.4%), Karp B (1/9, 
11.1%), Kato B (2/9, 22.2%), Gilliam (1/9, 11.1%), and JG_C (1/9, 11.1%) 
in the Myanmar patients (Figure 16). The genotype O. tsutsugamushi in 
the Myanmar study is more variable than in the previous South Korea 
study, and Karp_A was more abundant at 44.4%. I investigated all 152 
patients’ sera by checking for the O. tsutsugamushi specific tsa56 gene 
sequence. There was 1 sample (1/152, 0.65%) in which I detected the    
O. tsutsugamushi-specific tsa56 gene with a fever duration of 5 days, 
although this sample was negative for the O. tsutsugamushi-specific IgG 
antibody response in IFA method, but this patient had an eschar. In 119 
samples positive for the O. tsutsugamushi specific IgG antibody via IFA, 
Five samples were detected to have the O. tsutsugamushi-specific tsa56 
gene (≥1:160). In the case of IgM, among the 90 positive patients’ sera 
(≥1:40), there were 8 samples which were detected to have the         
O. tsutusgamushi-specific tsa56 gene.
2.6. Potential coinfection with O. tsutsugamushi and SFTSV
Based on the results of molecular and serological detection, 5 sera (5/152, 
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3.3%) were positive for the partial S segment of the SFTSV RNA genome, 
indicating SFTSV infection. Furthermore, 3 of the 5 carried high titers 
(≥1:2,560) of IgG and/or IgM antibodies specific to O. tsutsugamushi, as 
measured via IFA (Figure 15), suggesting coinfection with scrub typhus. 
All SFTSV-positive patients suffered with a fever for 5 to 7 days and 
recovered fully from febrile illness. There was 1 suspected patients’ 
serum (No.132 patient) having the SFTSV-specific IgG antibody. From the 
IFA method, this patients’ serum showed a positive result in staining the 
SFTSV plaque (≥1:320). Patient No.132 had eschar and muscle and joint 
pain symptoms. Moreover, this sample was positive for the               




Table 1. Summary of the characteristics of patients’sera positive with 
SFTSV-specific NP protein in South Korea 2000-2003
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Figure 1. Analysis of SFTSV NP-specific antibody responses in sera 
collected in South Korea during 2000-2003. The x-axis indicates the IDs 
of patient sera, and the y-axis indicates the optical density (O.D.) at 450 
nm. The figure shows some represented data in the year 2000 using the 
ELISA method. Positive samples and negative samples were shown in a 
cyan circle, gray circle, respectively. Positive controls from SFTSV 
infected patients’sera were drawn in red color. Cut-off titers was 
determined by using confirmed negative sera and indicated as red dashed 
line.
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Figure 2. Baseline characteristics of patients with positive IgG against 
SFTSV NP in South Korea 2000-2003. (A) Patient age distribution, (B) 
Patient gender distribution, (C) and (D) Timing of sample collection: Year 
and month, respectively.
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Figure 3. Immunofluorescence assay (IFA) to detect SFTSV-specific IgG 
antibody responses in patients’ sera collected in South Korea during 
2000-2003. SFTSV plaque was stained with the patients’sera with a 
serial dilution of the patients’sera titer and rabbit anti-SFTSV NP 
antibody as an internal positive control. The upper image is a positive 
patients’serum that presented the presence of SFTSV-specific IgG 
antibody response. The lower one is a negative sample that showed the 
absence of the presence of SFTSV-specific IgG antibody response. SFTSV 
plaque is stained by patients’serum shown by green color, SFTSV plaque 
is stained by a rabbit anti-SFTSV NP antibody shown in red color. DIC: 
Differential interference contrast. Bar: 100µm.
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Figure 4. Detection of SFTSV specific NP gene (123bp) by RT-PCR from the 
patients’ sera collected in South Korea during 2000-2003. Lane M, 100bp DNA 
ladder marker; lane (-) and (+), negative and positive control, respectively; Lane 
1 to 6, patients’ sera in 2000 year; Lane 7 to land 9, patients’ sera in 2001 
year; Lane 10 to land 19, patients’ sera in 2002 year; Lane 20 to land 37, 
patients’ sera in 2003 year. All these patients’sera were positive with SFTSV 
NP-specific ELISA.
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Figure 5. Phylogenetic tree of partial S (NP) sequences of SFTSV in 
South Korea. The partial S sequences from the stored sera collected from 
November 1, 2000, to November 1, 2003, that were analyzed in this study 
are shown in black circle compared with 19 representative genotype 
sequences. The partial S sequence data for the viruses identified in China, 
South Korea , and Japan were obtained from NCBI/BLAST.
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Figure 6. Antibody responses specific to O. tsutsugamushi in patients’ 
sera collected in South Korea during 2000-2003. The upper image is a 
positive patients’serum that presented an antibody specific for           
O. tsutsugamushi. The lower one is a negative sample that showed the 
absence of an antibody specific for O. tsutsugamushi. DIC: Differential 
interference contrast. O. tsutsugamushi (green color). Bar: 20µm.
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Figure 7. Detection of O. tsutsugamushi-specific tsa56 gene (483bp) by 
PCR from the patients’ sera collected in South Korea during 2000-2003. 
Lane M, 100 bp DNA marker; lane (-) and lane (+), negative and positive 
control, respectively. All these patients’ sera were positive with SFTSV 
NP-specific ELISA. The figure shows some represented data using the 
PCR method.
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Figure 8. Phylogenetic tree of O. tsutsugamushi-specific tsa56 gene 
sequences in South Korea. The tree was constructed using the maximum 
likelihood method with MEGA6. The tsa56 gene sequences identified in 
this study are indicated by black circles and compared with 17 
representative genotype sequences. The O. tsutsugamushi tsa56 gene 
sequence data identified from China, South Korea, Japan, and India were 
obtained from NCBI/BLAST.
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Table 2. Summary of the diagnosis results for tested patients’ sera 
collected in South Korea 2000-2003
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Table 3. Potential coinfection with O. tsutsugamushi and SFTSV in South 
Korea 2000-2003
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Table 4. Summary of the characteristics of patients with potential scrub 
typhus in Myanmar
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Figure 9. Map of Myanmar showing the locations of Sagaing and Magway 
provinces where patients’sera were collected
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Figure 10. Characteristics of 152 patients’sera with potential scrub typhus 
in Myanmar. (A) Patient age distribution, (B) Patient gender distribution
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Figure 11. Immunofluorescence assay (IFA) to detect SFTSV-specific IgG 
antibody responses in patients’sera in Myanmar. SFTSV plaque was 
stained with the patients’sera with a serial dilution of the patients’sera 
titer and rabbit anti-SFTSV NP antibody as an internal positive control. 
The upper image is a positive patients’serum that presented the presence 
of SFTSV-specific IgG antibody response. The lower one is a negative 
sample that showed the absence of the presence of SFTSV-specific IgG 
antibody response. SFTSV plaque is stained by patient serum shown by 
green color, SFTSV plaque is stained by a rabbit anti-SFTSV NP antibody 
shown in red color. DIC: Differential interference contrast. Bar: 100µm.
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Figure 12. Phylogenetic tree of partial S sequences of SFTSV in Myanmar. 
The tree was constructed using the maximum likelihood method with 
MEGA6. The partial the S sequences amplified from the sera of indicated 
patients were analyzed and shown in black circle and compared with 40 
representative genotype sequences. The partial S sequence data for the 
viruses identified in China, South Korea, and Japan were obtained from 
NCBI/BLAST.
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Figure 13. Initial serological diagnosis of patients’ sera in Myanmar by 
Immunochromatography test (ICT) strip. Representative images of ICT 
results detecting specific IgG against TSA56 and ScaA antigen in 
suspected scrub typhus patients’sera. The red band appearing on the 
control line (C) and test line (T) including TSA56 and ScaA line 
concurrently or either way was regarded as a positive (Strip 3,4,5). The 
test was considered as a negative when only the control band appeared as 
red (Strip 2). And if no band appeared on the control line, then the test 
was considered invalid. 
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Figure 14. Antibody response specific to O. tsutsugamushi in patients’sera 
in Myanmar. (A) O. tsutsugamushi-specific IgM antibody test.            
(B) O. tsutsugamushi-specific IgG antibody test. The upper image is a 
positive patients’serum that presented antibody specific for              
O. tsutsugamushi. The lower one is a negative sample that showed the 
absence of antibody-specific for O. tsutsugamushi. DIC: Differential 
interference contrast. O. tsutsugamushi (IgM-red color, IgG-green color). 
Bar: 20µm.
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Figure 15. Phylogenetic tree of O. tsutsugamushi-specific tsa56 gene 
sequences in Myanmar. The tree was constructed using the maximum 
likelihood method with MEGA6. The tsa56 gene sequences identified in 
this study are indicated by full black circles and compared with 17 
representative genotype sequences. The O. tsutsugamushi tsa56 gene 
sequence data identified from China, South Korea, Japan, and India were 
obtained from NCBI/BLAST.
- 52 -
Table 5. Summary of diagnosis results using patients’sera in Myanmar
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Severe fever with thrombocytopenia syndrome is a newly emerging viral 
disease in Asia that infects humans primarily through tick bites. 
Transmission from person to person has been confirmed in people with 
close contact such as family members and health-care workers, and 
asymptomatic infection via close contact from person to person has also 
been reported.  
Scrub typhus is an acute febrile illness caused by O. tsutsugamushi, a 
bacterium transmitted to humans through chigger mite (Acari: 
Trombiculiidae) bites. The vectors of SFTSV and O. tsutsugamushi are 
different; H. longicornis is a major vector of SFTSV and Leptotrombidium 
spp. mites are vectors of O. tsutsugamushi. However, a previous report 
showed that SFTSV was detected by RT-PCR in L. scutellare mite bites 
in China, suggesting that the mites are a potential vector for SFTSV; Wi et 
al. suggested the possibility of the coinfection with SFTSV and           
O. tsutsugamushi in South Korea. However, there has been no report of 
mixed infection with both SFTSV and different genotypes of              
O. tsutsugamushi in patients. In this study, I retrospectively confirmed 15 
SFTSV infections or mixed infection with O. tsutsugamushi by amplification 
of the partial S segment of the viral RNA and the bacterial DNA, as well 
as detection of IgM and/or IgG antibodies against SFTSV and             
O. tsutsugamushi from the stored sera of patients who had an acute febrile 
illness from November 1, 2000, to November 1, 2003, in South Korea. 
Although the case-fatality rate of scrub typhus is low due to antibiotic 
treatment, severe scrub typhus remains an unresolved issue. Due to the 
potential for a severe clinical form, a clinical prediction tool will be useful 
to narrow the differential diagnosis for those requiring further urgent 
investigation. 15 samples (15/37, 40.5%) were positive via IFA (≥1:160). 
9 samples (9/37, 24.3%) detected the specific PCR products NP gene. The 
number of infected patients with positive IFA had rapidly increased each 
year from 2000-2003. The total number of patients in the year 2000 was 
6. The year 2001 had 0 patients among the tested samples. The year 
2002 had 3 infected patients. But the number of patients in the year 2003 
dramatically increased to 6 patients out of 2,328 samples. Severe fever 
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with thrombocytopenia syndrome virus was previously reported in South 
Korea in 2010. Therefore, I suggest that SFTSV infections in South Korea 
occurred before the previously reported cases and were more concurrent 
with those in China.
Coinfection of O. tsutsugamushi with several other pathogens has been  
reported. Diseases shown to occur concurrently with scrub typhus include 
pneumonia caused by Mycoplasma pneumoniae52), murine typhus53), Q 
fever54), leptospirosis55), chicken pox56), malaria57), and dengue58). Several 
of the coinfection pathogens are susceptible to the antimicrobials used to 
treat scrub typhus. However, a coinfection should be suspected in scrub 
typhus patients if defervescence does not occur within 48-72 hours of 
appropriate antimicrobial treatment and combination therapy may be 
required59)60). Unusually, one O. tsutsugamushi coinfection may be 
advantageous to the patient. The clinical evidence on the possibility of the 
coinfection of O. tsutsugamushi and SFTSV is not solid, and further 
monitoring and study are necessary. From an ecological perspective, given 
the vectors of the two diseases, coinfection is rare. Although the epidemic 
seasons overlap and there is a risk of simultaneously acquiring the two 
diseases during outdoor activity, they do not share vectors, and the 
ecologies of their vectors differ. Phenotypically, scrub typhus is highly 
prevalent in the rice field areas of western and southwestern South Korea, 
whereas the incidence of SFTS is low in this area, consistent with the low 
SFTSV is high in the eastern and southeastern mountainous area of SFTS 
is low in this area, consistent with the low of SFTSV infection rate in 
ticks. Conversely, the incidence of SFTSV is high in the eastern and 
southeastern mountainous areas of South Korea61). In South Korea, 
following hospital records, by IFA method, some patient samples were 
positive with Hantavirus which caused Hemorrhagic fever and renal 
syndrome (HFRS), Leptospira caused Leptospirosis, and R. typhi caused 
murine typhus. Among 37 tested samples, there were 1 samples which 
were positive with Leptospira and 4 samples positive with R. typhi (Table 
1). 2 samples (2/37, 5.4%) were positive with SFTSV and R. typhi 
(≥1:1,280) in 2001. There was 1 sample (1/37, 2.7%) positive for all 
SFTSV and O. tsutsugamushi (≥1:2,560) and Leptospira (≥1:160) and 1 
sample (1/37, 2.7%) was positive for all SFTSV and O. tsutsugamushi 
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(≥1:2,560) and R. typhi (≥1:160) in 2002. There was 1 sample (1/37, 
2.7%) positive for SFTSV and R. typhi (≥1:80) in 2002. The possibility 
of coinfection with O. tsutsugamushi and another pathogen should also be 
considered, SFTSV is also can be coinfected with O. tsutsugamushi. 
Based on the results of the genetic detection of the two pathogens, among 
them 9 samples detected PCR product, there were 4 samples (4/37, 
10.8%) which showed coinfection between O. tsutsugamushi and severe 
fever with thrombocytopenia syndrome virus (SFTSV) by detecting both 
the SFTSV NP gene and O. tsutsugamushi-specific tsa56 gene. 4 samples 
showed coinfection between 2 kinds of the pathogen (Karp and Gilliam) 
which were all classified under the genotype of O. tsutsugamushi. 15 
patients’ sera (15/37, 40.5%) showed a positive result by staining the 
SFTSV plaque (≥1:160). 5 of 15 samples (5/37, 13.5%) were positive for 
both pathogens O. tsutsugamushi and SFTSV via the IFA method with titer 
≥1:1,280 and ≥1:160, respectively. The coinfection could happen in both 
pathogens O. tsutsugamushi and SFTSV. The coinfection could happen in 
both pathogen O. tsutsugamushi and SFTSV. The percentage of potential 
coinfection with O. tsutsugamushi and SFTSV is high and I can detect the 
pathogen-specific antibody responses at a high titer of antibody dilution. 
Sometimes patients had a primary infection, the initial infection caused by 
one pathogen such as SFTSV or O. tsutsugamushi, which can continue with 
secondary infection by a different pathogen (SFTSV or O. tsutsugamushi). 
It was considered as evidence for potential coinfection with the two 
pathogens O. tsutsugamushi and SFTSV. This study showed that the 
population over 60 years old included the highest number of patients at 14 
(14/37, 37.8%) compared to other age groups. The 37 patients 
investigated included 10 males (37.03%) and 27 females (72.97%). Due to 
a lack of information about the living area of the patients, I can give a 
hypothesis that was similar to the findings in other Asian areas62)63). Most 
infected farmers were elderly women ≥60 years old. These findings might 
be explained by the unbalanced development between rural and urban 
areas, which results in the problem of left-behind children, the elderly, 
and women. It included a higher probability of exposure to mites, ticks, or 
domestic animals with SFTSV and O. tsutsugamushi, and the frequency of 
latent infections or asymptomatic patients with both pathogens varied. 
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Person-to-person transmission of SFTSV has been demonstrated in both 
China and Korea. In these instances, the disease is typically fatal, with a 
high viral load in the blood observed following infection by contact with 
contaminants64)65).
In South Korea, scrub typhus is a major public health problem during the 
harvest season in South Korea (October and November); 10,485 cases 
were reported in 201357). In my study, the season with the highest number 
of patients positive for the SFTSV NP-specific antibody was November 
with 25 samples (25/37, 67.5%). In October and December, there were 5 
positive samples (5/37, 13.5%) and 3 positive samples (3/37, 8.1%), 
respectively. The incidence of SFTS showed obvious seasonal 
characteristics, having an overlap of seasonality between scrub typhus and 
SFTS.
The time point to collect the patients’ sera can determine the possibility 
of detection of the pathogen-specific IgG and IgM antibodies. In the South 
Korea surveillance, no samples could be detected with SFTSV NP-specific 
IgM antibodies. SFTSV NP-specific IgG antibodies were detected in the 
sera of 37 patients (37/2,328, 1.546%). 37 sera samples positive for 
anti-SFTSV NP IgG by ELISA were tested for IgG antibodies against    
O. tsutsugamushi using IFA. The IFA results used to detect IgG antibodies 
showed that O. tsutsugamushi specific IgG antibodies were detected in the 
sera of the 17 patients (17/37, 45.9%). No sample can be detected for the 
O. tsutsugamushi specific IgM antibody via IFA method. 
9 samples showed a clear genotype for O. tsutsugamushi with the 3 
genotypes Karp_C (6/37, 16.2%), Boryong (1/37, 2.7%), Gilliam (2/37, 
5.4%). 5 samples showed a mixed-infected O. tsutsugamushi strain (5/37, 
13.5%). By TA cloning, I was only capable of classifying strains isolated 
from mixed-infected O. tsutsugamushi in 2 samples. Both of them were 
mixed between Karp and Gilliam strains. In South Korea, the Boryong 
genotype is more prevalent. But in this study, Karp_C was shown to be 
more abundant than the other genotypes such as Boryong. This study 
could not represent the genotype distribution of O. tsutsugamushi in Korea. 
The signs and symptoms of SFTS and scrub typhus are similar, but SFTS 
exhibits a higher mortality rate than scrub typhus. Therefore, it is 
important to consider the possibility of SFTSV infection in patients having 
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scrub typhus potentially being coinfected with SFTSV. Thus, there is a 
need to better understand the ecological transmission dynamics and 
geographic distribution of SFTSV and O. tsutsugamushi in endemic 
countries.
Moreover, this study investigated the serological prevalence and genotypic 
diversity of O. tsutsugamushi in clinically-suspected scrub typhus patients 
in Myanmar for the first time since the 1940s. Sagaing province and 
Magway province are regions of Myanmar. In these two provinces, 
agriculture is the major occupation, including the growing of rice, wheat, 
sesame, peanut, tobacco, sesamum, and groundnuts. Patients’ 
work-related information was not surveyed in this study but scrub typhus 
in the southern parts of Korea and Japan was more prevalent in farmers 
or people involved in agricultural work66). Among the 152 suspected 
patients that suffered from the acute febrile illness, eschar was observed 
in 144 patients (144/152, 94.7%) and serological positive responses, either 
specific IgG and IgM against the bacterial pathogen, was 78.3% and 59.2%, 
respectively, as assessed by via IFA. Since I was only able to examine 
sera collected during the acute phase of infection and could not assess the 
rise of antibody titers in paired samples in the convalescent phase, I was 
not able to confirm the exact prevalence of scrub typhus in the suspected 
patients. Nevertheless, the relatively high prevalence of eschar, implying 
mite-biting, and high titers of antibodies against O. tsutsugamushi suggests 
that scrub typhus is still prevalent in Myanmar as previously reported in 
the 1940s67)68). Whilst eschar, which is the vasculitic skin reaction 
following bites from the infected chiggers, may assist in the diagnosis of 
scrub typhus, not all cases were accompanied by skin lesions in the 
setting of multiple exposures with chigger bites, the incidence of eschar is 
much less due to the impaired cellular immunity of the host74). Several 
recent studies conducted on the Thai-Myanmar border also identified 
scrub typhus as one of the major Rickettsioses among a mixed population 
of migrant workers, including those from Myanmar69). Of note, a high 
prevalence of scrub typhus in children was confirmed in two separate 
studies, as I also observed during this work. Therefore, young children 
with febrile illness should be carefully observed for early diagnosis and 
treatment of scrub typhus in the endemic area of Southern Asia70), and the 
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baseline levels of antibody titers against O. tsutsugamushi in healthy 
individuals need to be assessed to determine the cut-off titers for acute 
scrub typhus in the endemic region71).
Early clinical diagnosis of scrub typhus is hampered by difficulty in 
differentiating from other febrile infectious diseases. Moreover, performing 
sophisticated laboratory tests, such as IFA using bacterial cultures, is not 
feasible for scrub typhus in resource-limited settings, especially in many 
of the endemic countries of Southern Asia; accurate point-of-care testing 
(POCT) would be invaluable for patient diagnosis and management72). 
Here, I applied ICT to detect the prevalence of antibody responses against 
TSA56 and ScaA in patients as a rapid diagnostic method for 
point-of-care testing (POCT). 20 patients’ sera (20/36, 55.6%) showed 
positive IgG responses against both antigens and 5 samples (5/36, 13.9%) 
were positive for the ScaA antigen only, suggesting potential applicability 
of the ScaA antigen for the diagnosis of scrub typhus when simultaneously 
used with the TSA56 antigen, a dominant immunogen of O. tsutsugamushi 
73). However, the overall positive rate of the home-made ICT for acute 
infection was relatively low (41/128, 32%) when compared to IFA 
detecting IgG responses against the bacterial antigen (101/128, 78.9%). In 
a recent assessment of the diagnostic accuracy of commercially available 
ICT kits, the sensitivity and specificity were 20.9-23.3% and 74.4-81.4%, 
respectively, for acute specimens and 32.6-76.7% and 76.7-79.1%, 
respectively, for convalescent specimens74). The poor sensitivity of 
commercial ICTs and my current study when performed on acute 
specimens highlights the difficulties in prompt diagnosis of scrub typhus. 
Future research should be directed towards creating a new ICT method 
with an optimal combination of antigens from locally prevalent genotypes 
and/or nucleic acid-based detection75) to improve diagnostic accuracy in 
the early period of disease progression. Scrub typhus should remain high 
on the list of differential diagnosis when faced with undifferentiated clinical 
symptoms and signs as clinical parameters alone hardly discriminate 
between scrub typhus and others, thus a need for a high index of clinical 
suspicion coupled with reliable confirmatory tests. Rapid tests are 
promising which may aid in early diagnosis; however more studies are 
required to evaluate its reliability in endemic regions. 
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Genotyping O. tsutsugamushi by using amplified sequences of tsa56 genes 
revealed that at least five different genotypes (Karp_A (44.4%), Karp_B 
(11.1%), Kato_B (22.2%), Gilliam (11.1%), and JG_C (11.1%), are 
currently present in central Myanmar. In an earlier study using sera from 
15 scrub typhus patients in Myanmar (Burma) and the Philippine islands in 
1944 76), complement fixation tests typed the isolates as Gilliam (36%), 
Karp (7%), Seerangayee (7%), and mixed strains (50%). Another recent 
study also reported the presence of Gilliam and Karp strains in 3 patients 
of the central Thai-Myanmar border, as assessed by serotyping. My 
current study revealed genetic heterogeneity in Myanmar patients, similar 
to those observed in nearby countries including Bangladesh77), Northern 
Thailand78), and Laos79). This study highlights the importance of 
considering scrub typhus as a diagnostic possibility in cases of acute 
undifferentiated febrile illness in rural areas. Since then, there have been 
no reports describing the prevalence and genetics of O. tsutsugamushi in 
Myanmar. Scrub typhus is likely to remain an under-appreciated and 
under-diagnosed disease, which may be due to non-specific clinical 
presentation and the laborious nature of its diagnosis requirement. 
SFTS is a tick-borne viral disease endemic in Eastern Asia and has been 
reported in China, South Korea, Japan, and Vietnam. Recently, serological 
and genetic surveillance of SFTSV using sera from domestic animals and 
ticks (R. microplus) also showed SFTSV RNA and antibodies in animals 
and ticks in Taiwan80). Of note, the Taiwan Centers for Disease Control 
(Taiwan CDC) announced the first human case of SFTS on November 19, 
2019 (https://www.cdc.gov.tw/Bulletin). SFTSV has been found in humans, 
ticks, and animals. The anti-SFTSV antibodies positive ratios in domestic 
and wild animals were 43.58% (163/374) and 46.47% (112/241), 
respectively. SFTSV has a wide host range and infections in some animal 
species. The pooled seroprevalence of anti-SFTSV antibodies was 45.70% 
in goats and sheep, 36.70% in cattle, 29.50% in dogs, 9.6% in chickens, 
3.2% in rodents, and 3.2% in pigs. SFTSV RNA was also detected in blood 
samples from several animal species, with a carriage rate varying from 
0.23 to 26.31%. The highest carriage rate of SFTSV RNA was detected in 
cattle (up to 26.31%), followed by cats (17.46%), goats (9.1%), and 
rodents (8.44%), but there is no evidence that the virus can cause disease 
- 61 -
in animals. The intimate contact with animals increases the probability of a 
tick bite and this then increases the chances of SFTSV infection, and 
besides, contact with the secretions of infected animals may also be a 
route of transmission leading to SFTV infection90). Zhang and Xu (2016) 
reported that the status of SFTSV infection from domestic and wild 
animals was related to transmission from different tick species. They 
proposed a tick and migratory bird model for SFTSV transmission and a 
hypothesis for the local transmission and wide dissemination of SFTSV by 
combining infection data with host and vector ecology data. They also 
showed that the risk of infection is reduced if the animals and vector 
populations are monitored81).
Here, I retrospectively confirmed five SFTSV infections and mixed 
infection with O. tsutsugamushi by amplifying the partial S segment of the 
viral RNA and detection of IgM and/or IgG antibodies against             
O. tsutsugamushi from the sera of patients with acute febrile illness in 
Myanmar for the first time. The SFTSV-positive patients did not travel 
abroad and all five positive patients live in the same village in Sagaing 
province, suggesting that there are hot spots for SFTSV infection. Several 
different tick species, such as H. longicornis, R. microplus,                
A. testudinarium and I. nipponensis are reported as potential vectors for 
the transmission of SFTSV, although H. longicornis is known as the 
primary vector82).
The presence of R. microplus and A. testudinarium has been reported in 
Myanmar 83). Migratory birds might also function as long-distance carriers 
of virus-bearing ticks and disseminate SFTSV from endemic countries to 
tropical Southern Asia. Another important issue is the coinfection of 
SFTSV and O. tsutsugamushi. The primary vectors for scrub typhus are 
Leptotrombidium spp., especially L. deliense in south Asian Asian countries 
including Myanmar84). The coinfection of O. tsutsugamushi and SFTSV 
might be mediated by either simultaneous infestation by two different 
vectors carrying each pathogen or by a single tick or mite species 
carrying both pathogens. In China, SFTSV has been detected in L. 
scutellare mites85) and the coinfection of SFTSV with various bacterial 
pathogens has been reported in hard ticks, including H. longicornis86). A 
previous report showed that SFTSV was detected by RT-PCR in L. 
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scutellare mite bites in China, suggesting that the mites are a potential 
vector for SFTSV which suggests the possibility for coinfection with 
SFTSV and O. tsutsugamushi. In another study in China, the presence of 
tick-borne pathogens and their possible coinfections were evaluated among 
host-seeking ticks in seven cities from Jiaodong peninsula, Shandong 
Province, with specific PCR or reverse transcription-PCR tests. Coinfection 
of A. capra and SFTSV was also discovered from two female             
H. longicornis in Pingdu city. These results indicated that the potential 
human pathogens other than severe febrile and thrombocytopenic syndrome 
might be transmitted by hard ticks separately or in combination91).
Besides, coinfections of different tick-borne bacterial and viral pathogens 
in both humans and animals have been commonly reported in recent years 
87)88)89). Notably, coinfection with spotted fever group rickettsiae was 
identified in 77 of 823 patients infected with SFTSV in a study from 
China, and the coinfection resulted in delayed recovery and increased risk 
for death. In this study, all five SFTSV-positive patients recovered within 
a week, and four of them were less than 15 years old. Given that the 
disease severity of SFTS is significantly associated with the host’s age 
and the viral genotype90), milder clinical symptoms observed in the 
Myanmar patients might be due to earlier exposure and/or prevalence of 
less virulent genotypes of SFTSV in Myanmar. Therefore, continuous 
surveillance of SFTSV patients with detailed clinical manifestations and 
associated viral genotypes prevalent in the local area needs to be 
conducted. Coinfection contributes significantly to the diagnostic challenges 
of acute febrile illnesses, especially in endemic areas. The confusion 
caused by overlapping clinical features impedes timely management. In 
addition, more reliable differential diagnosis techniques and rational 
prevention and control measures are required for better clinical practices 
in the endemic regions of multiple ticks and mite-borne pathogens91)92). 
Further clinical, epidemiological, and laboratory research is also needed to 
better understand the ecological transmission dynamics and geographic 
distribution of SFTSV and O. tsutsugamushi93)94).
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쯔쯔가무시병은 오리엔시아 쯔쯔가무시 (Orientia tsutsugamushi)에 의한 감염으
로 발생하는 급성열성 감염질환이다. 중증 열성 혈소판 감소 증후군 바이러스 
(Severe Fever with Thrombocytopenia Syndrome Virus) 는 진드기 매개 바이
러스로, 출혈열을 유발한다. 중증 열성 혈소판 감소 증후군은 중국, 남한, 일본 등 
동아시아에서 나타나고 있으며, 이는 쯔쯔가무시병이 발생하는 지역과 일치한다. 쯔
쯔가무시병과 중증 열성 혈소판 감소증이 역학적, 임상학적으로 중첩되기 때문에 
이 매개체 감염 질환들의 지역적인 발병에 대한 이해는 목표지향적 조사와 치료 계
획 수립에 있어 매우 중요하다.
방법: 본 연구에서는 오리엔시아 쯔쯔가무시의 유전적 다양성, 그리고 한국과 미얀
마 내 오리엔시아 쯔쯔가무시와 중증 열성 혈소판 감소 증후군 바이러스와의 잠재
적 동시감염을 조사하고자 하였다. 이를 위하여 2000년부터 2003년까지 발병한 
한국의 열성 질환 환자 혈청 2,328개, 리케치아성 질환으로 진단받은 미얀마 환자 
152명의 혈청을 조사하였다. 쯔쯔가무시병과 중증 열성 혈소판 감소 증후군에 대한 
혈청학적, 분자적 검사를 시행하였으며, 두 병원체의 유전형은 혈청 시료에서 증폭
된 각 병원체의 유전자 시퀀싱을 통해 확정되었다.
결과: 한국의 2328개의 시료 중 14개에서 오리엔시아 쯔쯔가무시의 tsa56 특이적
인 유전자 증폭 산물을 발견하였으며, 보령 (1/37, 2.7%), 카프 (8/37, 21.6%) , 
길리암 (4/37, 10.8%) 등 최소 4가지 유전형이 존재함을 밝혀내었다. 나아가 9개
의 시료에서는 SFTSV의 NP 유전자 특이적인 유전자 증폭 산물이 탐지되었다. 9
개 중 3개의 시료에서 두 병원체 유전자가 동시에 확인 되었다. 미얀마 환자의 혈
청에서는 152개의 시료 중 9개의 시료에서 카프 A (4/9, 44.4%), 카프 B (1/9, 
11.1%), 가토 B (2/9, 22.2%), 길리암 (1/9, 11.1%), 그리고 JG_C (1/9, 
11.1%) 등 5개의 쯔쯔가무시균 유전형이 발견되었다. 또한 5개의 시료에서 
SFTSV의 np 유전자 특이적인 유전자 증폭 산물이 탐지되었다. 5개의 SFTSV 유
전자 양성시료는 모두 쯔쯔가무시균 유전자 음성이었으나, 세 개의 혈청시료에서 
쯔쯔가무시균에 대한 항체가 높은 역가(>1:2560)로 관찰되었다.  
결론: 2000년부터 2003년까지 한국 열성질환 환자, 그리고 2018년 수집된 미얀마
의 리케치아 질환 의심 환자의 혈청 시료에서 혈청학적, 분자적 추적조사를 통하여 
쯔쯔가무시병과 중증열성혈소판감소증의 혈청학적 유병률과 유전자 양성률을 확인
하였다. 또한 한국과 미얀마에서 유행하는 쯔쯔가무시균의 유전형 다양성을 확인하
였으며, 쯔쯔가무시균과 중증열성혈소판감소증후군 바이러스의 동시감염을 진단하
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였다. 따라서 초기 증상이 유사한 절지동물매개 감염질환의 감별진단과 유행하는 
유전형 다양성에 대한 보다 자세한 조사를 통해 유행지역에서의 진단과 치료 전략
을 수립하는데 필요한 정보들을 확대할 필요성이 있음을 제안하고자 한다. 
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